These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35446800)

  • 41. Partial splenectomy in sickle cell syndromes.
    Nouri A; de Montalembert M; Revillon Y; Girot R
    Arch Dis Child; 1991 Sep; 66(9):1070-2. PubMed ID: 1929516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of Thromboelastogram in monitoring the activation of the coagulation pathway and assessing the associated risk factors for hypercoagulable state in transfusion dependent thalassemia patients.
    Shastry S; Mohan G; Pa P; Mundkur S; Kurien A; Ahammad J
    Transfus Apher Sci; 2023 Apr; 62(2):103583. PubMed ID: 36344327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancy.
    Berman RS; Feig BW; Hunt KK; Mansfield PF; Pollock RE
    Ann Surg; 2004 Nov; 240(5):852-7. PubMed ID: 15492568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
    Ang AL; Lim CY; Ng WY; Lam JCM
    Transfusion; 2021 Sep; 61(9):2566-2577. PubMed ID: 34258773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thrombocytosis following splenectomy: with or without additional organ resection.
    Oida T; Kano H; Mimatsu K; Kawasaki A; Kuboi Y; Fukino N; Kida K; Amano S
    Hepatogastroenterology; 2012 Jun; 59(116):1033-5. PubMed ID: 22580653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
    Aessopos A; Farmakis D; Deftereos S; Tsironi M; Polonifi A; Moyssakis I; Diamanti-Kandaraki E; Papalambros E
    Ann Hematol; 2005 Jun; 84(6):353-7. PubMed ID: 15711802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Compact Differential Dynamic Microscopy-based Device (cDDM): An Approach Tool for Early Detection of Hypercoagulable State in Transfusion-Dependent-β-Thalassemia Patients.
    Petiwathayakorn T; Paradee N; Hantrakool S; Jarujareet U; Intharah T; Srichairatanakool S; Koonyosying P
    ACS Appl Bio Mater; 2024 Jul; 7(7):4710-4724. PubMed ID: 38920024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of splenectomy in adult chronic immune thrombocytopenia.
    Zoghlami-Rintelen C; Weltermann A; Bittermann C; Kyrle PA; Pabinger I; Lechner K; Wenzl E
    Ann Hematol; 2003 May; 82(5):290-4. PubMed ID: 12739064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Venous thrombosis in haemoglobin H disease after splenectomy.
    Tso SC; Chan TK; Todd D
    Aust N Z J Med; 1982 Dec; 12(6):635-8. PubMed ID: 6962715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Splenectomy for Cooley's disease in children. (Considerations on 52 cases)].
    Ruggo A; Georgacopulo P
    Minerva Med; 1968 Dec; 59(102):5672-88. PubMed ID: 5707474
    [No Abstract]   [Full Text] [Related]  

  • 51. Splenectomy in Thalassemia: The Role of Surgery as an Adjunct to Medical Management.
    Kumar S; Chauhan S
    Cureus; 2024 Jun; 16(6):e62834. PubMed ID: 39036111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changing patterns of splenectomy in transfusion-dependent thalassemia patients.
    Piga A; Serra M; Longo F; Forni G; Quarta G; Cappellini MD; Galanello R
    Am J Hematol; 2011 Sep; 86(9):808-10. PubMed ID: 21850661
    [No Abstract]   [Full Text] [Related]  

  • 53. Prognostic Factors for Immune Thrombocytopenic Purpura Remission after Laparoscopic Splenectomy: A Cohort Study.
    Kwiatkowska A; Radkowiak D; Wysocki M; Torbicz G; Gajewska N; Lasek A; Kulawik J; Budzyński A; Pędziwiatr M
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 31003557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Partial embolization of the spleen in patients with thalassemia.
    Stanley P; Shen TC
    J Vasc Interv Radiol; 1995; 6(1):137-42. PubMed ID: 7703580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of partial and total splenectomy in children with sickle cell disease using an Internet-based registry.
    Mouttalib S; Rice HE; Snyder D; Levens JS; Reiter A; Soler P; Rothman JA; Thornburg CD
    Pediatr Blood Cancer; 2012 Jul; 59(1):100-4. PubMed ID: 22238140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thalassemia intermedia and recurrent priapism following splenectomy.
    Macchia P; Massei F; Nardi M; Favre C; Brunori E; Barba V
    Haematologica; 1990; 75(5):486-7. PubMed ID: 2097271
    [No Abstract]   [Full Text] [Related]  

  • 57. Radiofrequency ablation of the spleen in patients with thalassemia intermedia: a pilot study.
    Rasekhi AR; Naderifar M; Bagheri MH; Shahriari M; Foroutan H; Karimi M; Nabavizadeh SA
    AJR Am J Roentgenol; 2009 May; 192(5):1425-9. PubMed ID: 19380572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the Relationship Between Hb F Levels and Nucleated Red Blood Cells with Morbidity in Non Transfusion-Dependent Thalassemia Patients.
    Karimi M; Jooya P; Haghpanah S; Mokhtari M; Rezaei N; Fath M; Parand S
    Hemoglobin; 2016 Aug; 40(4):250-6. PubMed ID: 27211282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of splenectomy on lymphocyte populations in thalassemia major].
    Ballart IJ; Díez RA; Estévez ME; Sen L; Goicoa MA; de Miani SA; Peñalver J
    Sangre (Barc); 1985; 30(2):137-45. PubMed ID: 4012516
    [No Abstract]   [Full Text] [Related]  

  • 60. Review of disease-related complications and management in adult patients with thalassemia: A multi-center study in Thailand.
    Chuncharunee S; Teawtrakul N; Siritanaratkul N; Chueamuangphan N
    PLoS One; 2019; 14(3):e0214148. PubMed ID: 30893381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.